Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-10-05 1:03 pm Sale |
2021-09-30 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
EcoR1 Capital LLC | 81,077 0.200% |
-5,000,000 (-98.40%) |
Filing History |
| 2021-09-30 4:05 pm Purchase |
2021-09-20 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Venrock Healthcare Capital Partners II, L.P. | 3,427,461 8.100% |
3,427,461 (New Position) |
Filing History |
| 2021-09-23 3:14 pm Purchase |
2021-09-22 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
EcoR1 Capital LLC | 5,081,077 12.000% |
1,501,700 (+41.95%) |
Filing History |
| 2021-09-22 5:21 pm Sale |
2021-09-20 | 13D | Corvus Pharmaceuticals, Inc. CRVS |
ORBIMED ADVISORS LLC | 6,943,654 16.400% |
-1,109,644 (-13.78%) |
Filing History |
| 2021-09-22 08:31 am Purchase |
2021-09-21 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
TANG CAPITAL PARTNERS LP | 3,736,184 8.800% |
3,736,184 (New Position) |
Filing History |
| 2021-08-04 5:21 pm Unchanged |
2021-08-02 | 13D | Corvus Pharmaceuticals, Inc. CRVS |
ORBIMED ADVISORS LLC | 8,053,298 19.000% |
0 (Unchanged) |
Filing History |
| 2021-05-11 4:06 pm Purchase |
2021-05-04 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
EcoR1 Capital LLC | 3,579,377 8.500% |
3,579,377 (New Position) |
Filing History |
| 2021-02-17 5:08 pm Purchase |
2021-02-17 | 13D | Corvus Pharmaceuticals, Inc. CRVS |
ORBIMED ADVISORS LLC | 8,053,298 21.980% |
1,285,714 (+19.00%) |
Filing History |
| 2021-02-12 9:18 pm Purchase |
2020-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
MILLER RICHARD A MD | 2,179,559 7.500% |
220,417 (+11.25%) |
Filing History |
| 2021-02-12 4:09 pm Sale |
2020-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
BIOTECHNOLOGY VALUE FUND L P | 2,898,797 9.990% |
-22,380 (-0.77%) |
Filing History |
| 2020-07-09 4:29 pm Sale |
2020-07-07 | 13D | Corvus Pharmaceuticals, Inc. CRVS |
Novo Holdings A/S | 1,389,498 4.970% |
-1,538,062 (-52.54%) |
Filing History |